Pharmacoeconomic Comparison of Anaprazole and I...

By Melike Belenli Gümüş

July 2, 2024

Introduction Peptic ulcer disease (PUD) affects 5%–10% of the global po...
The Role of Real-World Evidence in CMS Price Negotiations
The Significant Bias in Nutrition Research Due to Food Composition Variability
Clinical Trial Screening with GPT-4: The RECTIFIER Framework
A New Approach to Cardiovascular Risk Assessment for Statin Therapy
A Cost-Saving Life-Saver: The Impact of Palivizumab in Columbia
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Enhancing Surgical Recovery Predictions with AI: A New Approach
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness